
Approvals· May 26, 2026 · 8 min read
Novel FDA drug approvals Q1-Q2 2026: the fifteen drugs and their formulary implications
By Ran Chen#FDA Approval#Novel Drug Approvals#GLP-1
Annual FDA novel drug approval reviews, first-in-class mechanisms, formulary impact, and mid-year access implications for new molecular entities.
